BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3
20 results:

  • 1. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with pancreatic, Colorectal, Lung, or Ovarian cancer.
    Mattox AK; Douville C; Wang Y; Popoli M; Ptak J; Silliman N; Dobbyn L; Schaefer J; Lu S; Pearlman AH; Cohen JD; Tie J; Gibbs P; Lahouel K; Bettegowda C; Hruban RH; Tomasetti C; Jiang P; Chan KCA; Lo YMD; Papadopoulos N; Kinzler KW; Vogelstein B
    Cancer Discov; 2023 Oct; 13(10):2166-2179. PubMed ID: 37565753
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. cancerization of ducts in hilar cholangiocarcinoma.
    Lee JW; Zhang Y; Yoshizawa T; Argani P; Wood LD; Oshima K
    Virchows Arch; 2022 Aug; 481(2):1-10. PubMed ID: 35527321
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. mecom permits pancreatic acinar cell dedifferentiation avoiding cell death under stress conditions.
    Backx E; Wauters E; Baldan J; Van Bulck M; Michiels E; Heremans Y; De Paep DL; Kurokawa M; Goyama S; Bouwens L; Jacquemin P; Houbracken I; Rooman I
    Cell Death Differ; 2021 Sep; 28(9):2601-2615. PubMed ID: 33762742
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel combination of percutaneous stenting with iodine-125 seed implantation and chemotherapy for the treatment of pancreatic head cancer with obstructive jaundice.
    Chi Z; Chen L; Huang J; Jiang N; Zheng Q; Huang N; Yang W
    Brachytherapy; 2021; 20(1):218-225. PubMed ID: 33158777
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer.
    Krepline AN; Geurts JL; Akinola I; Christians KK; Clarke CN; George B; Ritch PS; Khan AH; Hall WA; Erickson BA; Griffin MO; Evans DB; Tsai S
    HPB (Oxford); 2020 Dec; 22(12):1745-1752. PubMed ID: 32354656
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. prdm3 attenuates pancreatitis and pancreatic tumorigenesis by regulating inflammatory response.
    Ye J; Huang A; Wang H; Zhang AMY; Huang X; Lan Q; Sato T; Goyama S; Kurokawa M; Deng C; Sander M; Schaeffer DF; Li W; Kopp JL; Xie R
    Cell Death Dis; 2020 Mar; 11(3):187. PubMed ID: 32179733
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. evi1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.
    Tanaka M; Shibahara J; Ishikawa S; Ushiku T; Morikawa T; Shinozaki-Ushiku A; Hayashi A; Misumi K; Tanaka A; Katoh H; Sakuma K; Kokudo T; Inagaki Y; Arita J; Sakamoto Y; Hasegawa K; Fukayama M
    Virchows Arch; 2019 Jan; 474(1):39-46. PubMed ID: 30349952
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by evi1 in AML.
    Dzneladze I; Woolley JF; Rossell C; Han Y; Rashid A; Jain M; Reimand J; Minden MD; Salmena L
    PLoS One; 2018; 13(2):e0191510. PubMed ID: 29415082
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Accurate grading of pancreatic neuroendocrine tumors with Ki-67 index in fine-needle aspiration specimens: a comparative cytologic and histologic study].
    He SR; Cui D; Gong H; Zhu YP; Chen L; Hu ST; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):393-399. PubMed ID: 28591986
    [No Abstract]    [Full Text] [Related]  

  • 10. evi1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma.
    Yasui K; Konishi C; Gen Y; Endo M; Dohi O; Tomie A; Kitaichi T; Yamada N; Iwai N; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Tanaka S; Arii S; Itoh Y
    Cancer Sci; 2015 Jul; 106(7):929-37. PubMed ID: 25959919
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. pancreatic adenocarcinoma: MRI conspicuity and pathologic correlations.
    Legrand L; Duchatelle V; Molinié V; Boulay-Coletta I; Sibileau E; Zins M
    Abdom Imaging; 2015 Jan; 40(1):85-94. PubMed ID: 25030776
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. miR-92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation.
    He G; Zhang L; Li Q; Yang L
    Biomed Pharmacother; 2014 Feb; 68(1):25-30. PubMed ID: 24332650
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort.
    Stolzenberg-Solomon RZ; Schairer C; Moore S; Hollenbeck A; Silverman DT
    Am J Clin Nutr; 2013 Oct; 98(4):1057-65. PubMed ID: 23985810
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. evi1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis.
    Tanaka M; Suzuki HI; Shibahara J; Kunita A; Isagawa T; Yoshimi A; Kurokawa M; Miyazono K; Aburatani H; Ishikawa S; Fukayama M
    Oncogene; 2014 May; 33(19):2454-63. PubMed ID: 23752186
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Role of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in diagnosing metastasis to the pancreas: a tertiary center experience.
    Hijioka S; Matsuo K; Mizuno N; Hara K; Mekky MA; Vikram B; Hosoda W; Yatabe Y; Shimizu Y; Kondo S; Tajika M; Niwa Y; Tamada K; Yamao K
    Pancreatology; 2011; 11(4):390-8. PubMed ID: 21894056
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk.
    Genkinger JM; Spiegelman D; Anderson KE; Bernstein L; van den Brandt PA; Calle EE; English DR; Folsom AR; Freudenheim JL; Fuchs CS; Giles GG; Giovannucci E; Horn-Ross PL; Larsson SC; Leitzmann M; Männistö S; Marshall JR; Miller AB; Patel AV; Rohan TE; Stolzenberg-Solomon RZ; Verhage BA; Virtamo J; Willcox BJ; Wolk A; Ziegler RG; Smith-Warner SA
    Int J Cancer; 2011 Oct; 129(7):1708-17. PubMed ID: 21105029
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Diagnostic accuracy of multidetector-row computed tomography for hilar cholangiocarcinoma.
    Akamatsu N; Sugawara Y; Osada H; Okada T; Itoyama S; Komagome M; Shin N; Cho N; Ishida T; Ozawa F; Hashimoto D
    J Gastroenterol Hepatol; 2010 Apr; 25(4):731-7. PubMed ID: 20074166
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Indications for endoscopic ultrasound and diagnosis on fine-needle aspiration and cytology.
    Hussain T; Salamat A; Farooq MA; Hassan F; Hafeez M
    J Coll Physicians Surg Pak; 2009 Apr; 19(4):223-7. PubMed ID: 19356336
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Probability of pancreatic cancer following diabetes: a population-based study.
    Chari ST; Leibson CL; Rabe KG; Ransom J; de Andrade M; Petersen GM
    Gastroenterology; 2005 Aug; 129(2):504-11. PubMed ID: 16083707
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The use of endoscopic ultrasound-guided fine-needle aspiration for investigation of submucosal and extrinsic masses of the colon and rectum.
    Sasaki Y; Niwa Y; Hirooka Y; Ohmiya N; Itoh A; Ando N; Miyahara R; Furuta S; Goto H
    Endoscopy; 2005 Feb; 37(2):154-60. PubMed ID: 15692931
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.